Drug
Amx0114
Amx0114: highest development phase Phase 1, developed by Amylyx Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Amylyx Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| AMX0114 NCT06665165 | Phase 1 | ALS |
Latest
No recent events.
Follow Amx0114 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.